Readers' Comments on "Reassessing Smoore: Mistakes, Crisis, and the Way Forward"

Industry Insight by 2FIRSTS
Jan.04.2024
Readers' Comments on "Reassessing Smoore: Mistakes, Crisis, and the Way Forward"
2FIRSTS released an article titled "Reassessing Smoore: Mistakes, Crisis, and the Way Forward", sparking widespread discussion in the e-cigarette industry.

On January 3rd, 2FIRSTS published an in-depth article titled "Rethinking Smoore: Mistakes, crisis, and a way forward". The article immediately sparked widespread discussion within the e-cigarette industry.

 

2FIRSTS has conducted a comprehensive summary of various perspectives on the Smoore issue thus far. The aim is to provide readers with a more comprehensive viewpoint for further contemplation and discussion.

 

Below are the various perspectives: 

 

@migao: 

 

The missed opportunity in the disposable business and the late push with two major clients are closely related. Smoore mainly operates as an OEM business, meaning that no matter how great its technology is, it is in vain if customers do not utilize it. This inherent passivity in Smoore's role explains why it fell behind in the disposable market. Had BAT positioned themselves earlier in the disposable market, Smoore would have naturally kept up. After all, the technology required for disposable products is relatively low, and Smoore already possessed accumulated enough to meet the product demands.

 

Speculating further, it can be said that the tobacco industry in the UK and the US is not as quick to embrace disposables, not because they are unaware of the trend but rather because they are cautious about entering into cutthroat competition. Up until 2022, they may have held on to the hope that disposables would not gain popularity, considering the significant profit gap compared to pod-based systems. However, they eventually realized that they couldn't ignore the trend and had to personally engage in the market. Losing market share is more terrifying than sacrificing profits.

 

Therefore, based on the aforementioned points, it is not surprising that Smoore's lagging behind in the market carries a certain degree of expected sorrow.

 

The game of major client and the demand for optimizing supply chain costs for major clients have been clearly reflected in the past year in British American Tobacco and RELX. This year, British American Tobacco has placed 50% or even more of its disposable business with FirstUnion. Although they have introduced multiple new products this year, the main existing models and a new flagship model are now dominated by FirstUnion. This directly led to Smoore's failure to achieve its target of 4 billion in disposable business at the beginning of the year. If it had not been transferred to FirstUnion, Smoore's disposable business this year would have been around 50-60, but I estimate it will be around 35. RELX also experienced a similar situation, where the domestic market shifted from being solely supplied by Smoore to being shared by Smoore, FirstUnion, and ALD. As for the overseas market, I do not have the data, but I conservatively estimate that Smoore now accounts for less than 40%.

 

@Keepupthegoodwork:

 

The entire article fails to mention Smoore's compliance issues, such as PMTA, which is the fundamental reason why it has not entered the US market. In the European market, disposable companies have violated TPD rules by entering with a large number of products, which is also a significant reason why Smoore has not collaborated with these companies. Therefore, Smoore's current situation is largely due to various policy reasons, not its research and development efforts. Additionally, it should be noted that half of Smoore's research and development investment is allocated to HNB products, not solely disposable products, which the articles have failed to mention.

 

@999Roses:

 

In my impression, this seems to be the most detailed article analyzing Smoore. After reading it several times, I feel both disappointed by the setback of a giant and reassured by glimpses of hope. I am someone who believes in the power of time and believes in the order of the world. The road for e-cigarettes is still very long. The market will eventually move away from prioritizing growth data. At that time, the ultimate winner will be the one with the safest product and sufficient trust. There is a saying in the business world, "Don't compare who has a more glamorous life, but who can live longer." Yes, I believe Smoore is the company that will always be at the table.

 

Anonymous user:

 

Smoore has missed out on the best period of overseas development, which is both a strategic misjudgment and a result of their difficulty in ignoring external regulations. They are a company with long-term plans and have not made any fundamental mistakes in major decisions. However, China and overseas markets are two different playing fields, and therefore require two different approaches. Nevertheless, Smoore has once flourished, but it now appears increasingly quiet in the face of external capital speculation.

 

Anonymous User:

 

Smoore's investment is long-term and represents recognition of the regulatory trends surrounding e-cigarette compliance and the regulation of similar tobacco products. Due to requirements for compliance as a public company, Smoore cannot dramatically increase production orders. Additionally, as the tobacco industry is dominated by a few key players, Smoore must maintain strong relationships with these market leaders. In the short term, the e-cigarette market is not yet in a highly regulated era, so Smoore's second growth phase will not occur just yet. As a technology-driven company, Smoore must focus on iterating and innovating its vaporization technology, controlling factory costs, and betting on its new vaporization technology consumer products becoming popular. However, it is still too early to say whether these strategies will be successful.

 

It is even uncertain whether Smoore will remain standing until the day the mist clears.

 

An User on Xueqiu:

 

The analysis is sound, but it is unclear whether the author intentionally or unintentionally overlooked an important point - the importance of compliance and the impact of strong regulation on competition. RELX and Smoore's success was achieved in an environment without stringent regulation, which proved their capabilities as a manufacturer and brand. However, in the later years, the industry faced strong regulation, which noticeably affected major players like RELX and Smoore. On the other hand, new small and medium-sized manufacturers could take advantage of regulatory loopholes for penetration and development of new products, without facing the same restrictions. As a result, RELX and Smoore found themselves constrained within a very limited space, making the competition unequal. The decline in their market share, apart from not keeping up with e-cigarette consumer trends, can largely be attributed to this unfair competition. However, running fast doesn't guarantee running far. From a regulatory standpoint, e-cigarettes are burdened with "original sin." Therefore, compliance with regulations, legality, and ESG (Environmental, Social, and Governance) initiatives are the basic guarantees for companies to persist in the long run. RELX and Smoore possess much stronger capabilities in these aspects compared to other new players, although this often goes unnoticed.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Altria Showcases Ploom, Marlboro Heated Tobacco Sticks and Non-Nicotine Energy Products at NACS Show 2026
Altria Showcases Ploom, Marlboro Heated Tobacco Sticks and Non-Nicotine Energy Products at NACS Show 2026
At the 2026 NACS Show, Altria displayed Ploom devices alongside imagery of Marlboro-branded heated tobacco sticks, while also featuring RIOT Energy and Proper Wild non-nicotine products. The booth showcased on! PLUS nicotine pouches, including 12 mg variants not listed among FDA-authorized products as of October 9, and NJOY e-cigarettes. Altria also presented convenience-store traffic figures highlighting its retail presence. 2Firsts examines the company's expanded product portfolio, non-nicotine business activities and the regulatory status of products displayed at the show.
EXPO
Oct.10
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India's Ministry of Health and Family Welfare has directed states to step up enforcement against nicotine pouch sales, citing increased availability through online and offline channels and concern about nicotine exposure among children. Reuters reported that international brands including ZYN and White Fox are being sold in India. A study led by ICMR-NICPR found pouches in seven of 10 surveyed locations and identified 68 brands and 445 flavors online. Separately, India's Drugs Technical Advisory Board recommended in August that no new nicotine formulation be approved.
Regulations
Sep.28 by 2Firsts Perspectives
Product | Philip Morris Korea Launches Two TEREA ONYX Capsule Tobacco Sticks, Expanding Portfolio to Five Lines
Product | Philip Morris Korea Launches Two TEREA ONYX Capsule Tobacco Sticks, Expanding Portfolio to Five Lines
Philip Morris Korea launched TEREA ONYX, a new tobacco stick line for IQOS ILUMA devices, on October 15, 2026. The initial products, AMANG PEARL and CALI PEARL, feature tropical-inspired flavors, Fresh Filters and capsules designed to deliver different flavor experiences before and after activation. Both are priced at KRW 4,800 per pack and are available at convenience stores nationwide and IQOS-operated stores in South Korea. The launch expands the Korean TEREA portfolio from four product lines to five, following earlier capsule tobacco stick additions in 2026.
product
Oct.23
2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
China exported $979 million of vape-related products in August 2026, up 3.3% from a year earlier but down 6.4% from July. The UK replaced the U.S. as the main source of growth: UK-bound shipments jumped 51.4% to a 2026 high of $177 million, while exports to the U.S. fell 12.4% to $339 million. Shipments to markets outside the U.S. increased 14.2%, broadening growth beyond the market that had driven July’s rebound.
News
Sep.23 by 2Firsts Perspectives